SEARCH

SEARCH BY CITATION

References

  • 1
    Kudenchuk PJ. Advanced cardiac life support antiarrhythmic drugs. Cardiol Clin. 2002; 20:7987.
  • 2
    Nolan JP, De Latorre FJ, Steen PA, Chamberlain DA, Bossaert LL. Advanced life support drugs: do they really work? Curr Opin Crit Care. 2002; 8:2128.
  • 3
    Van Walraven C, Stiell IG, Wells GA, Hebert PC, Vandemheen K. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group. Ann Emerg Med. 1998; 32:54453.
  • 4
    American Heart Association. 2005 guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2005; 112:IV1.
  • 5
    Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol. 2003; 91:15D26D.
  • 6
    Nattel S, Duker G, Carlsson L. Model systems for the discovery and development of antiarrhythmic drugs. Prog Biophys Mol Biol. 2008; 98:32839.
  • 7
    Stiell IG, Wells GA, Hebert PC, Laupacis A, Weitzman BN. Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad Emerg Med. 1995; 2:26473.
  • 8
    U.S. Census Bureau. King County, Washingon. QuickFacts from the US Census Bureau. 2008; Available at: http://quickfacts.census.gov/qfd/states/53/53033.html. Accessed December 17, 2008.
  • 9
    Cummins RO, Chamberlain DA, Abramson NS, et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation. 1991; 84:96075.
  • 10
    Rea TD, Eisenberg MS, Becker LJ, Murray JA, Hearne T. Temporal trends in sudden cardiac arrest: a 25-year emergency medical services perspective. Circulation. 2003; 107:27805.
  • 11
    McEvoy GK, Litvak K, Welsh OH. AHFS Drug Information 2001, first ed. Bethesda, MD: American Society of Health-System Pharmacists, 2001.
  • 12
    Giardina EG, Heissenbuttel RH, Bigger JT Jr. Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure. Ann Intern Med. 1973; 78:18393.
  • 13
    Gorgels AP, Van Den Dool A, Hofs A, et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol. 1996; 78:436.
  • 14
    American Heart Association. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. In collaboration with the International Liaison Committee on Resuscitation. Circulation. 2000; 102:I1.
  • 15
    Klungel OH, Martens EP, Psaty BM, et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol. 2004; 57:122331.